(Q39500545)

12 September 2017

title

Human papillomavirus type 16 E6 inhibits p21(WAF1) transcription independently of p53 by inactivating p150(Sal2). (English)

1 reference

12 September 2017

main subject

human papilloma virus

1 reference

human papillomavirus

29 September 2024

Peggy Parroche

1

1 reference

12 September 2017

Majid Touka

2

1 reference

12 September 2017

Mariam Mansour

3

1 reference

12 September 2017

Véronique Bouvard

4

1 reference

12 September 2017

Amélie Thépot

5

1 reference

12 September 2017

Rosita Accardi

6

1 reference

12 September 2017

Christine Carreira

7

1 reference

12 September 2017

Guillaume G Roblot

8

1 reference

12 September 2017

Bakary S Sylla

9

1 reference

12 September 2017

Uzma Hasan

10

1 reference

12 September 2017

Massimo Tommasino

11

1 reference

12 September 2017

language of work or name

English

0 references

publication date

26 July 2011

1 reference

12 September 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

12 September 2017

volume

417

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

443-448

1 reference

Skin human papillomavirus type 38 alters p53 functions by accumulation of deltaNp73.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

WAF1, a potential mediator of p53 tumor suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

Cell cycle sibling rivalry: Cdc2 vs. Cdk2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

A tumor host range selection procedure identifies p150(sal2) as a target of polyoma virus large T antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

p150(Sal2) is a p53-independent regulator of p21(WAF1/CIP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

Identification of a novel activity of human papillomavirus type 16 E6 protein in deregulating the G1/S transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

The human papillomavirus E6 protein and its contribution to malignant progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

Mechanisms of human papillomavirus-induced oncogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

The RB and p53 pathways in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

C/EBP{delta} and STAT-1 are required for TLR8 transcriptional activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.05.016

10.1016/J.VIROL.2011.05.016

7 January 2021

Identifiers

DOI

1 reference

release_p5mnw2heozckxnrgn447dkzfva

12 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p5mnw2heozckxnrgn447dkzfva

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference